HAS
61
-2
SO
50
6
LB
29
-13
APD
49
4
AVB
32
5
PEP
50
2
LH
50
-3
HON
70
2
SCHW
56
-2
PPL
64
2
COP
42
-5
DAL
72
2
FDX
50
-3
CAG
47
3
PX
56
-4
RIG
41
-2
WYNN
49
15
ROP
35
-3
CL
62
3
KMI
59
2
HAS
61
-2
SO
50
6
LB
29
-13
APD
49
4
AVB
32
5
PEP
50
2
LH
50
-3
HON
70
2
SCHW
56
-2
PPL
64
2
COP
42
-5
DAL
72
2
FDX
50
-3
CAG
47
3
PX
56
-4
RIG
41
-2
WYNN
49
15
ROP
35
-3
CL
62
3
KMI
59
2
Financhill
Back

ProShares UltraShort MSCI Emerging Markets Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Sell
40

EEV
ProShares UltraShort MSCI Emerging Markets

Last Price:
$20.27
Seasonality Move:
-4.52%
Sell
33

ZBIO
Zenas BioPharma, Inc.

Last Price:
$36.94
Seasonality Move:
-8.13%
Sell
40
ProShares UltraShort MSCI Emerging Markets (EEV) is a Sell

Is ProShares UltraShort MSCI Emerging Markets a Buy, Sell or Hold?

  • The current ProShares UltraShort MSCI Emerging Markets [EEV] share price is $20.03. The Score for EEV is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • EEV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Zenas BioPharma, Inc. (ZBIO) is a Sell

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $32.59. The Score for ZBIO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • ZBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EEV Stock Price Chart

What is ProShares UltraShort MSCI Emerging Markets's stock price today?

  • The ProShares UltraShort MSCI Emerging Markets share price today is $20.03
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EEV is experiencing buying pressure, which is a positive indicator for future bullish movement.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $32.59
    The current trend is moderately bullish and ZBIO is experiencing selling pressure, which indicates risk of future bearish movement.

EEV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 54.9 Buy
Chaikin Money Flow: 3687 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.25 - 20.19) Buy
Bollinger Bands (100): (19.27 - 23.05) Sell

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.39 Buy
Relative Strength Index (14 RSI): 42.51 Sell
Chaikin Money Flow: -433025 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.8 - 39.38) Sell
Bollinger Bands (100): (16.79 - 33.43) Buy

EEV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.66 Buy
20-day SMA: 19.89 Buy
50-day SMA: 19.65 Buy
200-day SMA: 25.12 Sell
8-day EMA: 19.74 Buy
20-day EMA: 19.73 Buy
50-day EMA: 20.05 Sell
200-day EMA: 24.31 Sell

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.44 Sell
20-day SMA: 37.66 Sell
50-day SMA: 32.27 Buy
200-day SMA: 17.45 Buy
8-day EMA: 37.61 Sell
20-day EMA: 34.32 Sell
50-day EMA: 23.15 Buy
200-day EMA: 7.97 Buy

ProShares UltraShort MSCI Emerging Markets Earnings Growth & EEV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

ProShares UltraShort MSCI Emerging Markets Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):